Subscribe on iTunes.
This episode of the Posh Corps Podcast investigates Peace Corps' use of the anti-malarial drug Mefloquine. This story is the third segment in The Reform Series, a four-part series about Peace Corps reform efforts.
Mefloquine, also known by the brand name Lariam, is an anti-malarial drug that has been prescribed to Peace Corps Volunteers since 1989. Mefloquine is effective at preventing malaria, but some believe that the adverse side effects of the drug may be just as dangerous as malaria itself.
Sara Thompson served as a Peace Corps Volunteer in Burkina Faso from 2010 to 2012. She experienced serious adverse side effects from Mefloquine use during service, and the side effects did not end when she stopped taking the drug.
Transcript:
Credits:
Produced and recorded by Alan Toth.
Recording and editorial assistance by Lauren Schwartzman.
Music: "A Tale" from the album Hang by Laura Inserra. Used under a license provided by iLicense Music.
Sources:
Interviews with Sara Thompson and Dr. Remington Nevin
A lesson learnt: the rise and fall of Lariam and Halfan
CDC: Medicines for the Prevention of Malaria While Traveling Mefloquine
AP: Elite Army Units to Stop Taking Anti-Malarial Drug
Thomas Wilkinson: The Positive Deviant, Forget what others are saying, and decide for yourselves
Peace Corps Technical Guideline 840 PREVENTION OF MALARIA
JAAPL: Psychiatric Side Effects of Mefloquine: Applications to Forensic Psychiatry
Dr. Remington Nevin: Letter To Peace Corps Director Carrie Hessler-Radelet